From €3374EUR$3,500USD£2,886GBP
- Report
- January 2024
- 91 Pages
Global
From €3500EUR$3,889USD£3,098GBP
- Report
- October 2023
- 77 Pages
Global
From €3500EUR$3,889USD£3,098GBP
- Report
- October 2023
- 77 Pages
Global
From €3500EUR$3,889USD£3,098GBP
- Report
- October 2023
- 72 Pages
Global
From €3500EUR$3,889USD£3,098GBP
- Report
- January 2021
- 150 Pages
China, Global
From €3000EUR$3,333USD£2,656GBP
- Report
- October 2023
- 146 Pages
Global
From €3401EUR$3,528USD£2,909GBP
€4001EUR$4,150USD£3,422GBP
- Report
- March 2024
- 132 Pages
Global
From €916EUR$950USD£783GBP
- Report
- December 2020
- 99 Pages
Global
From €4338EUR$4,500USD£3,710GBP
- Report
- September 2020
- 84 Pages
Global
From €4338EUR$4,500USD£3,710GBP
- Report
- March 2022
- 236 Pages
Global
From €5562EUR$5,769USD£4,757GBP
- Report
- December 2021
- 251 Pages
Global
From €5947EUR$6,168USD£5,086GBP
- Report
- April 2021
- 178 Pages
Global
From €5562EUR$5,769USD£4,757GBP
- Report
- October 2023
- 140 Pages
Global
From €2891EUR$2,999USD£2,473GBP
- Report
- September 2023
- 160 Pages
Global
From €2891EUR$2,999USD£2,473GBP
- Report
- May 2023
- 147 Pages
Global
From €5784EUR$5,999USD£4,946GBP
The Bioabsorbable Stent market is a subset of the larger Stent market. Bioabsorbable Stents are medical devices used to treat coronary artery disease. They are made of biodegradable materials that dissolve over time, allowing the artery to return to its natural state. This type of stent is advantageous over traditional metal stents, as it eliminates the need for a second procedure to remove the stent. Bioabsorbable Stents are also beneficial in that they reduce the risk of restenosis, a condition in which the artery becomes blocked again after stent placement.
Notable companies in the Bioabsorbable Stent market include Abbott, Biotronik, Elixir Medical, and Biosensors International. Show Less Read more